J.W. Cole Advisors Inc. Has $88,000 Stock Holdings in VBI Vaccines Inc. (NASDAQ:VBIV)
J.W. Cole Advisors Inc. Has $88,000 Stock Holdings in VBI Vaccines Inc. (NASDAQ:VBIV)
J.W. Cole Advisors Inc. trimmed its position in VBI Vaccines Inc. (NASDAQ:VBIV – Get Rating) by 27.4% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 53,100 shares of the biopharmaceutical company's stock after selling 20,000 shares during the period. J.W. Cole Advisors Inc.'s holdings in VBI Vaccines were worth $88,000 at the end of the most recent quarter.
根据J.W.Cole Advisors Inc.最近提交给美国证券交易委员会(美国证券交易委员会)的13F文件,该公司在第一季度将其在VBI疫苗公司(VBI Vaccines Inc.)的头寸削减了27.4%。在此期间,该公司出售了20,000股票,拥有这家生物制药公司53,100股票。截至最近一个季度末,J.W.Cole Advisors Inc.持有的VBI疫苗价值8.8万美元。
A number of other hedge funds have also modified their holdings of the company. E Fund Management Co. Ltd. raised its holdings in VBI Vaccines by 98.1% during the 1st quarter. E Fund Management Co. Ltd. now owns 53,148 shares of the biopharmaceutical company's stock worth $88,000 after buying an additional 26,320 shares during the period. GSA Capital Partners LLP acquired a new stake in VBI Vaccines during the 4th quarter worth approximately $257,000. Nisa Investment Advisors LLC raised its holdings in VBI Vaccines by 1,099.6% during the 1st quarter. Nisa Investment Advisors LLC now owns 126,800 shares of the biopharmaceutical company's stock worth $210,000 after buying an additional 116,230 shares during the period. Grimes & Company Inc. raised its holdings in VBI Vaccines by 19.6% during the 1st quarter. Grimes & Company Inc. now owns 281,077 shares of the biopharmaceutical company's stock worth $467,000 after buying an additional 46,116 shares during the period. Finally, Wealthsource Partners LLC acquired a new stake in VBI Vaccines during the 1st quarter worth approximately $238,000. 39.96% of the stock is currently owned by institutional investors and hedge funds.
其他一些对冲基金也调整了对该公司的持股。易方达基金管理有限公司在第一季度增持VBI疫苗98.1%。易方达基金管理有限公司现在持有53,148股这家生物制药公司的股票,价值88,000美元,在此期间又购买了26,320股。GSA Capital Partners LLP在第四季度收购了VBI疫苗公司的新股份,价值约25.7万美元。NISA Investment Advisors LLC在第一季度将其在VBI疫苗的持有量增加了1099.6%。NISA Investment Advisors LLC现在持有这家生物制药公司的12.68万股票,价值21万美元,在此期间又购买了116,230股票。Grimes&Company Inc.在第一季度将其在VBI疫苗公司的持股增加了19.6%。Grimes&Company Inc.现在持有281,077股这家生物制药公司的股票,价值467,000美元,在此期间又购买了46,116股。最后,Wealthsource Partners LLC在第一季度收购了VBI疫苗公司价值约23.8万美元的新股份。该公司39.96%的股票目前由机构投资者和对冲基金持有。
VBI Vaccines Price Performance
VBI疫苗的价格表现
NASDAQ VBIV opened at $0.73 on Friday. The company has a quick ratio of 2.19, a current ratio of 2.29 and a debt-to-equity ratio of 0.20. VBI Vaccines Inc. has a 12-month low of $0.64 and a 12-month high of $3.49. The company has a market capitalization of $189.22 million, a PE ratio of -1.88 and a beta of 1.86. The firm's 50 day moving average is $0.93 and its 200-day moving average is $1.09.
纳斯达克VBIV上周五开盘报0.73美元。该公司的速动比率为2.19,流动比率为2.29,债务权益比为0.20。VBI疫苗公司的股价为0.64美元的12个月低点和3.49美元的12个月高位。该公司市值为1.8922亿美元,市盈率为-1.88,贝塔系数为1.86。该公司的50日移动均线切入位在0.93美元,200日移动均线切入位在1.09美元。
Analyst Ratings Changes
分析师评级发生变化
Separately, Raymond James dropped their target price on shares of VBI Vaccines from $6.00 to $5.00 and set a "strong-buy" rating on the stock in a report on Tuesday, August 9th.
另外,雷蒙德·詹姆斯在8月9日周二的一份报告中将VBI疫苗的目标价从6.00美元下调至5.00美元,并将该股的评级定为“强力买入”。
About VBI Vaccines
关于VBI疫苗
(Get Rating)
(获取评级)
VBI Vaccines Inc, a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection.
VBI疫苗公司是一家生物制药公司,开发和销售用于治疗传染病和免疫肿瘤学的疫苗。该公司提供一种预防性乙肝疫苗Sci-B-Vac。它还参与VBI-2601(BRII-179)的开发,VBI-2601(BRII-179)是治疗慢性乙肝感染的免疫治疗候选药物。
See Also
另请参阅
- Get a free copy of the StockNews.com research report on VBI Vaccines (VBIV)
- What Steelcase's Earnings Say About the Return to the Office?
- The Institutions Hold On To Darden Restaurants International
- These 3 Big Dividend Payers Also Boast Strong Price Growth
- Is The Golden Age Of Homebuilding Already Over?
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- 免费获取StockNews.com关于VBI疫苗的研究报告(VBIV)
- 斯蒂尔凯斯的收益说明了他重返办公室的原因吗?
- 这些机构持有达顿餐饮国际公司的股份
- 这三大股利支付者也拥有强劲的价格增长
- 住房建设的黄金时代已经结束了吗?
- 天然气价格继续回升,这些股票应该会受益
Receive News & Ratings for VBI Vaccines Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VBI Vaccines and related companies with MarketBeat.com's FREE daily email newsletter.
每天收到VBI疫苗的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对VBI疫苗和相关公司的最新新闻和分析师评级的每日简要摘要。